Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial (Q43238337)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2010
edit
Language Label Description Also known as
English
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
scientific article published in January 2010

    Statements

    Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial (English)
    Anton L Pozniak
    Javier Morales-Ramirez
    Dewald Steyn
    Sergio H Lupo
    Mario Santoscoy
    Laurence T Rimsky
    Simon Vanveggel
    Katia Boven
    TMC278-C204 Study Group
    1 January 2010
    55-65

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit